Markets are near all-time highs as we enter 2017. The Trump rally, as many are calling it, helped push the markets to these highs but it still has to be seen if this rally is fundamentally sound. Perhaps the best litmus test for these fundamentals is looking at earnings.
24/7 Wall St. has put together a list of few companies that are reporting this week. We have included the consensus estimates from Thomson Reuters as well as a recent trading history and consensus price target.
Looking ahead at a different set of fundamentals, a few other biotech and pharma companies are expecting decisions from the U.S. Food and Drug Administration (FDA) in both January and February. These FDA decisions have the potential to push these stocks massively.
Sonic Corp. (NASDAQ: SONC) is scheduled to release its fiscal first-quarter financial results after the markets close on Wednesday. The consensus estimates call for $0.21 in earnings per share (EPS) and $130.7 million in revenue. The same period of last year reportedly had $0.24 in EPS and $145.8 million in revenue. Shares of Sonic traded down 2% to $25.95 on Tuesday, with a consensus analyst price target of $27.21 and a 52-week range of $21.12 to $36.34.
Constellation Brands Inc. (NYSE: STZ) is set to report its fiscal third-quarter earnings before the markets open on Thursday. Thomson Reuters is calling for $1.71 in EPS and $1.8 billion in revenue. In the third-quarter of last year, it posted EPS of $1.42 and $1.64 billion in revenue. Shares were trading at $153.98, in a 52-week range of $130.23 to $173.55. The stock has a consensus price target of $180.06.
Monsanto Co. (NYSE: MON) releases its fiscal first-quarter earnings report before the markets open on Thursday. Consensus estimates are $0.01 in EPS on revenue of $2.28 billion. The same period from last year had a net loss of $0.11 per share and $2.22 billion in revenue. Monsanto traded at $104.92 a share on Tuesday, within a 52-week range of $83.73 to $114.26. The consensus price target is $119.50.
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is expected to announce its fiscal first-quarter earnings report early Thursday as well. The consensus estimates are $1.09 in EPS and $29.24 billion in revenue, compared with last year’s EPS of $1.03 and revenue of $29.03 billion. Shares traded at $82.68. The consensus price target is $93.15, and a 52-week range is $71.50 to $88.00.